FDA Approves Eli Lilly's Zepbound Weight-Loss Drug for Sleep Apnea
An Eli Lilly & Co. Zepbound injection pen placed in the Brooklyn borough of New York, U.S., on Thursday, March…
Biotechnology and pharmaceuticals
Merck signs weight loss pills licensing agreement with Hansoh Pharma
Exterior view of the entrance to Merck headquarters on February 5, 2024 in Rahway, New Jersey. Spencer Platt | fake…
Eli Lilly's Zepbound Weight Loss Drug No Longer in Shortage
An injectable pen of Zepbound, Eli Lilly's weight loss drug, is on display in New York City on December 11,…
Ozempic faces scrutiny over possible risk of eye condition
A box of Ozempic manufactured by Novo Nordisk is seen in a pharmacy in London, Britain, March 8, 2024. Hollie…
We're adding to our position in a stock that just got some big support from Wall Street.
Shortly after the bell rings, we will buy 300 shares of Bristol Myers Squibb at approximately $56.50. Following the deal,…
UnitedHealth Group CEO Andrew Witty Addresses Death of Brian Thompson
Andrew Witty, CEO of UnitedHealth Group, testifies during the Senate Finance Committee hearing titled “Hacking America's Health Care: Assessing Cyberattack's…
We want to increase our ownership of a portfolio stock that just increased its dividend.
Every weekday, the CNBC Investing Club with Jim Cramer publishes Homestretch, a helpful afternoon update just in time for the…
Ro to Offer Zepbound Vials of Weight Loss Drug Working with Eli Lilly
Patients will be able to access Zepbound single-dose vials in Ro Courtesy: Ro Direct-to-consumer healthcare startup Ro said Wednesday that…
Healthcare Stocks Fall After Warren PBM Bill, Brian Thompson Shooting
UnitedHealth Group signs are displayed on a monitor on the floor of the New York Stock Exchange. Michael Nagle |…
The agreement with Novo Nordisk Catalent is closer to closing
A view of the Novo Nordisk logo at the company's office in Bagsvaerd, outside Copenhagen, Denmark, on March 8, 2024.…